Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice

被引:114
作者
Amorij, J-P. [1 ]
Saluja, V. [1 ]
Petersen, A. H. [2 ]
Hinrichs, W. L. J. [1 ]
Huckriede, A. [3 ]
Frijlink, H. W. [1 ]
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Lab Med, NL-9713 AV Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands
关键词
influenza vaccine; respiratory tract; dry powder formulation;
D O I
10.1016/j.vaccine.2007.10.035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study pulmonary vaccination with a new influenza subunit vaccine powder was evaluated. Vaccine powder was produced by spray-freeze drying (SFD) using the oligosaccharide inulin as stabilizer. Immune responses after pulmonary vaccination of BALB/c mice with vaccine powder were determined and compared to those induced by intramuscular and pulmonary vaccination with a conventional liquid subunit vaccine. All vaccinations were performed without adjuvant. Pulmonary vaccination with liquid subunit vaccine resulted in systemic Immoral (IgG) immune responses similar to intramuscular immunization. In contrast, the vaccine powder delivered by the pulmonary route, induced not only systemic Immoral (IgG) responses, but also cell-mediated (II-4, IFN-gamma) and mucosal immune responses (IgA, IgG). This study demonstrates that the combination of pulmonary antigen delivery and antigen powder production by SFD improves the immunogenic potential of (influenza subunit) antigen. In conclusion, vaccination with a non-adjuvanted SFD subunit vaccine powder by inhalation might be feasible and could be an alternative to conventional parenteral vaccine administration. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8707 / 8717
页数:11
相关论文
共 66 条
[1]  
AMIDI M, 2006, VACCINE
[2]   Rational design of an influenza subunit vaccine powder with sugar glass technology: Preventing conformational changes of haemagglutinin during freezing and freeze-drying [J].
Amorij, J.-P. ;
Meulenaar, J. ;
Hinrichs, W. L. J. ;
Stegmann, T. ;
Huckriede, A. ;
Coenen, F. ;
Frijlink, H. W. .
VACCINE, 2007, 25 (35) :6447-6457
[3]  
[Anonymous], EUR PHARM IMM METH 2
[4]   Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus [J].
Asahi-Ozaki, Y ;
Yoshikawa, T ;
Iwakura, Y ;
Suzuki, Y ;
Tamura, S ;
Kurata, T ;
Sata, T .
JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (02) :328-335
[5]  
BECK SE, 1999, PED PULM S, P228
[6]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[7]   Non-invasive pulmonary aerosol delivery in mice by the endotracheal route [J].
Bivas-Benita, M ;
Zwier, R ;
Junginger, HE ;
Borchard, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 61 (03) :214-218
[8]   Protective role of gamma interferon during the recall response to influenza virus [J].
Bot, A ;
Bot, S ;
Bona, CA .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6637-6645
[9]   Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults [J].
Boyce, TG ;
Hsu, HH ;
Sannella, EC ;
Coleman-Dockery, SD ;
Baylis, E ;
Zhu, YW ;
Barchfeld, O ;
DiFrancesco, A ;
Paranandi, M ;
Culley, B ;
Neuzil, KM ;
Wright, PF .
VACCINE, 2000, 19 (2-3) :217-226
[10]   LUNG MACROPHAGES - HOW MANY KINDS ARE THERE - WHAT DO THEY DO [J].
BRAIN, JD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03) :507-509